{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:45:56Z","timestamp":1792752356590,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jmoldx.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T06:55:35Z","timestamp":1787295335000},"page":"859-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utilization of Next-Generation Sequencing (NGS) in Unexplained Cytopenia"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4671-2148","authenticated-orcid":false,"given":"Zohre","family":"Sadeghian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill A.","family":"Lyapichev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-563X","authenticated-orcid":false,"given":"Mark J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Diacovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4641-2217","authenticated-orcid":false,"given":"Chakra","family":"Chaulagain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3664-3449","authenticated-orcid":false,"given":"Chieh-Lin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Bosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-2792","authenticated-orcid":false,"given":"Amir","family":"Behdad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2026.07.008_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib2","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.humpath.2012.10.006","article-title":"Bone marrow evaluation in new-onset pancytopenia","volume":"44","author":"Weinzierl","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib4","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib5","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/EDBK_239083","article-title":"CHIP, CCUS, and other acronyms: definition, implications, and impact on practice","volume":"39","author":"DeZern","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/ajh.25592","article-title":"The diagnostic utility of targeted gene panel sequencing in discriminating etiologies of cytopenia","volume":"94","author":"Zheng","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib9","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2024024756","article-title":"Risk prediction for clonal cytopenia: multicenter real-world evidence","volume":"144","author":"Xie","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib10","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib11","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2013-03-492884","article-title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","volume":"122","author":"Malcovati","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12308-023-00538-7","article-title":"The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory","volume":"16","author":"Bruehl","year":"2023","journal-title":"J Hematop"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000044","article-title":"Clinical utility of next-generation sequencing in the management of myeloproliferative neoplasms: a single-center experience","volume":"2","author":"Alduaij","year":"2018","journal-title":"Hemasphere"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.mayocp.2019.04.007","article-title":"Clinical applications and utility of a precision medicine approach for patients with unexplained cytopenias","volume":"94","author":"Mangaonkar","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/ajcp\/aqv023","article-title":"Identification of factors affecting the success of next-generation sequencing testing in solid tumors","volume":"145","author":"Goswami","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/ijlh.13747","article-title":"Reducing cytogenetic testing in the era of next generation sequencing: are we choosing wisely?","volume":"44","author":"Kawata","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib18","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1182\/blood.2019001610","article-title":"Clinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopenias","volume":"134","author":"Shanmugam","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib19","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/cncr.22570","article-title":"Myelodysplastic syndromes: incidence and survival in the United States","volume":"109","author":"Ma","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib20","first-page":"496","article-title":"Age-related clonal hematopoiesis","volume":"131","author":"Shlush","year":"2018","journal-title":"Blood J Am Soc Hematol"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood.2021010815","article-title":"Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia","volume":"138","author":"Tsaknakis","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib22","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2015-08-667063","article-title":"MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance","volume":"126","author":"Kwok","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib23","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1182\/bloodadvances.2021006649","article-title":"A predictive model for bone marrow disease in cytopenia based on noninvasive procedures","volume":"6","author":"Tr\u00e6den","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib24","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ajh.24554","article-title":"Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes","volume":"91","author":"Hansen","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2026.07.008_bib25","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/bloodadvances.2020003976","article-title":"Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826001443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157826001443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:25:16Z","timestamp":1792751116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157826001443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1525157826001443"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.07.008","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of Next-Generation Sequencing (NGS) in Unexplained Cytopenia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the Association for Molecular Pathology and American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}